Devoted to Amyloidosis: AstraZeneca’s Heartfelt Commitment at ISA 2024
AstraZeneca and Alexion will present at the International Symposium on Amyloidosis (ISA) 2024, showcasing studies on their amyloidosis treatment...
AstraZeneca and Alexion will present at the International Symposium on Amyloidosis (ISA) 2024, showcasing studies on their amyloidosis treatment...
Tennessee Cancer Specialists (TCS), an East Tennessee oncology group, has partnered with Sarah Cannon Research Institute (SCRI), a leading...
SpyBiotech and The University of Oxford have entered a research agreement to develop a vaccine against Epstein-Barr virus (EBV)....
Fulgent Pharma, a subsidiary of Fulgent Genetics, will present Phase 1 clinical data on FID-007, its lead therapeutic candidate...
Allez Health, a cutting-edge biosensor company specializing in continuous glucose monitoring (CGM), has secured $60 million in Series A+...
Gilead Sciences announced significant research findings to be presented at the European Association for the Study of the Liver...
AngioDynamics, Inc. has obtained CE Mark approval in Europe for its AlphaVac F1885 System, enabling the non-surgical removal of...
Foundation Medicine has launched FoundationOne®RNA, an RNA sequencing test that complements its DNA-based FoundationOne®CDx. This combination provides enhanced fusion...
PathAI, a leader in AI-powered pathology, launches an Early Access Program (EAP) for its AISight Image Management System (IMS)...
CRIO, a leading eSource provider, has secured a substantial investment from The Riverside Company. This funding will accelerate the...